Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors-Reference-Cited by-同舟云学术

Identification of a potent and metabolically stable series of fluorinated diphenylpyridylethanamine-based cholesteryl ester transfer protein inhibitors

Published:2012-10 Issue:20 Volume:22 Page:6503-6508
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Miller Michael M.,Liu Yalei,Jiang Ji,Johnson James A.,Kamau Muthoni,Nirschl David S.,Wang Yufeng,Harikrishnan Lalgudi,Taylor David S.,Chen Alice Ye A.,Yin Xiaohong,Seethala Ramakrishna,Peterson Tara L.,Zvyaga Tatyana,Zhang Jun,Huang Christine S.,Wexler Ruth R.,Poss Michael A.,Michael Lawrence R.,Adam Leonard P.,Salvati Mark E.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference67 articles.

1. (a) World Health Organization. Atlas of Heart Disease and Stroke; World Health Organization: Geneva, Switzerland, 2004.

2. (b) National Center for Health Statistics. Health, United States, 2005 with Chartbook on Trends in the Health of Americans; National Center for Health Statistics: Hyattsville, MD, 2005, p 178.

3. (c) Lloyd-Jones, D.; Adams, R.; Brown, T.M.; Carnethon, M.; Dai, S.; De Simone, G.; Ferguson, T.B.; Furie, K.; Gillespie, C.; Go, A.; Greenlund, K.; Haase, N.; Hailpern, S.; Ho, M.; Howard, V.; Kissela, B.; Kittner, S.; Lackland, D.; Lisabeth, L.; Marelli, A.; McDermott, M.; Meigs, J.; Mozaffarian, D.; Mussolino, M.; Nichol, G.; Roger, V.; Rosamond, W.; Sacco, R.; Sorlie, P.; Stafford, R.; Thom, T.; Wasserthiel-Smoller, S.; Wong, N.; Wylie-Rosett, J. Heart Disease and Stroke Statistics-2010 Update; A Report from the American Heart Association: Dallas, TX, 2008. Circulation 2010, 121, e1.

4. Systematic Review on the Risk and Benefit of Different Cholesterol-Lowering Interventions

5. Statins: Scandinavian Simvastatin Survival Study Group Lancet 1994, 344, 1383

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018–2022);European Journal of Medicinal Chemistry;2023-08

2. Fluorinated Cycloalkyl Building Blocks for Drug Discovery;ChemMedChem;2022-10-05

3. Spirocycle MmpL3 Inhibitors with Improved hERG and Cytotoxicity Profiles as Inhibitors of Mycobacterium tuberculosis Growth;ACS Omega;2021-01-13

4. Potential Inhibitors of the Activity of the Cholesterol-Ester Transfer Protein;Journal of Computational Biology;2019-12-01

5. Last of the gem-Difluorocycloalkanes: Synthesis and Characterization of 2,2-Difluorocyclobutyl-Substituted Building Blocks;The Journal of Organic Chemistry;2019-04-16